tert-Butyl 4-bromo-3-formylbenzoate

Catalog No. :
ACZSJM135
CAS No. :
1329170-75-3
Molecular Formula :
C12H13BrO3
Molecular Weight :
285.14

IUPAC Name:tert-butyl 4-bromo-3-formylbenzoate

tert-Butyl 4-bromo-3-formylbenzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$58.00Login to see priceIn stockInquiry
250mg95%$98.00Login to see priceIn stockIn stock
1g95%$269.00Login to see priceIn stockIn stock
5g95%$675.00Login to see priceIn stockIn stock
25g95%$3274.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-bromo-3-formylbenzoate
IUPAC Nametert-butyl 4-bromo-3-formylbenzoate
MDL No.MFCD31650587
Molecular FormulaC12H13BrO3
Molecular Weight285.14
SMILESO=C(OC(C)(C)C)C1=CC=C(Br)C(C=O)=C1
InChI KeyFSYXQDFLVYJNID-UHFFFAOYSA-N
SynonymBenzoic acid, 4-bromo-3-formyl-, 1,1-dimethylethyl ester;tert-Butyl 4-bromo-3-formylbenzoate;1,1-Dimethylethyl 4-bromo-3-formylbenzoate
CAS No.1329170-75-3
PubChem CID123216411

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZSJM135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHEMD948 route compound structure diagram
    ACHEMD948347174-28-1 In Stock
  2. Then
  3. ACZSJM135 route product structure diagram
    ACZSJM1351329170-75-3 In Stock
Inquiry

2. ACZSJM135 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKMVG547 route compound structure diagram
    ACKMVG54759247-47-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZSJM135 route product structure diagram
    ACZSJM1351329170-75-3 In Stock
Inquiry

Comments (0)